IL6 and chronic kidney disease: In CKD stages 2–5, simultaneous measurement of an inflammatory marker (IL-6), lipid markers, and kidney injury indices revealed that IL-6, BUN, and hemoglobin (Hb) levels differed significantly across stages, and these markers were risk factors for disease progression.